Chemoinformaics analysis of 2-Butene-1,4-diol
Molecular Weight | 88.106 | nRot | 2 |
Heavy Atom Molecular Weight | 80.042 | nRig | 11 |
Exact Molecular Weight | 88.0524 | nRing | 0 |
Solubility: LogS | -4.758 | nHRing | 0 |
Solubility: LogP | 4.556 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 14 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 13.6183 |
nHD | 2 | BPOL | 8.02566 |
QED | 0.669 |
Synth | 3.815 |
Natural Product Likeliness | 3.205 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.008 |
Pgp-sub | 0 |
HIA | 0.005 |
CACO-2 | -4.358 |
MDCK | 0.0000124 |
BBB | 0.863 |
PPB | 0.940468 |
VDSS | 1.314 |
FU | 0.0831773 |
CYP1A2-inh | 0.176 |
CYP1A2-sub | 0.533 |
CYP2c19-inh | 0.143 |
CYP2c19-sub | 0.883 |
CYP2c9-inh | 0.29 |
CYP2c9-sub | 0.782 |
CYP2d6-inh | 0.012 |
CYP2d6-sub | 0.776 |
CYP3a4-inh | 0.095 |
CYP3a4-sub | 0.216 |
CL | 13.007 |
T12 | 0.116 |
hERG | 0.006 |
Ames | 0.007 |
ROA | 0.047 |
SkinSen | 0.172 |
Carcinogencity | 0.038 |
EI | 0.827 |
Respiratory | 0.83 |
NR-Aromatase | 0.024 |
Antiviral | No |
Prediction | 0.984927 |